Katalytic Therapeutics

Unspecified (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£870,759

Jan 24 - Jan 27

Evaluating novel mutant-selective PDE4D PROTACs for the treatment of Acrodysostosis Type 2

MRC award to Keele University and Melissa Bowerman

Sep 22 - Mar 26

Selective PROTACS against PDE5 + PDE7 as novel treatments for CNS disorders and cancer

MRC award to University of Glasgow

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}